|
Human natural killer cells: Advancing biology and clinical applications
|
7R35CA210087-02
|
$992,214
|
$992,214
|
CALIGIURI, MICHAEL
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-07
|
$369,725
|
$184,863
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-05
|
$721,537
|
$721,537
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-11A1
|
$2,500,000
|
$900,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
|
5R01CA195519-03
|
$238,425
|
$238,425
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Optimizing Busulfan: Efficacy Toxicity and Pharmacometabolomics
|
5R01CA182963-06
|
$515,038
|
$515,038
|
MCCUNE, JEANNINE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
$279,751
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
$95,150
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
$4,813
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity
|
1R01CA228465-01
|
$404,275
|
$404,275
|
ZENG, DEFU
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Protective role of Honokiol in preventing c-Met-induced post-transplantation cancer
|
1R01CA222355-01
|
$411,068
|
$411,068
|
PAL, SOUMITRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
|
5R01CA193675-03
|
$404,888
|
$404,888
|
PAL, SOUMITRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-20
|
$2,247,411
|
$179,793
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Myeloid Malignancies
|
5P50CA206963-02
|
$2,300,000
|
$138,000
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation
|
5R01CA218486-02
|
$661,266
|
$661,266
|
HUSSAIN, SHEHNAZ
|
CEDARS-SINAI MEDICAL CENTER
|
|
KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN
|
5R01CA181050-05
|
$291,828
|
$291,828
|
PULSIPHER, MICHAEL
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Highly Sensitive Chimerism Testing to Detect Early Leukemia Relapse Post-Allo-Transplantation
|
1R41CA232805-01
|
$173,566
|
$173,566
|
KANAAN, SAMI
|
CHIMEROCYTE, INC.
|
|
Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications After Intensive Cancer Therapy in Pediatrics
|
1R21CA223503-01A1
|
$207,495
|
$207,495
|
DANDOY, CHRISTOPHER
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
5R01CA193350-04
|
$356,850
|
$356,850
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
|
5P01CA142106-14
|
$1,630,446
|
$1,630,446
|
CUTLER, COREY
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S1
|
$445,796
|
$8,916
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S2
|
$59,495
|
$1,190
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S3
|
$62,500
|
$1,250
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S4
|
$149,528
|
$2,991
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S5
|
$60,691
|
$1,214
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S6
|
$228,108
|
$4,562
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S7
|
$199,806
|
$3,996
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
5P30CA006516-53
|
$11,504,298
|
$230,086
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Integrative Oncogenomics of Multiple Myeloma (1 of 2)
|
3P01CA155258-07S1
|
$264,750
|
$29,123
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INST
|
|
Integrative Oncogenomics of Multiple Myeloma (2 of 2)
|
3P01CA155258-07S2
|
$88,250
|
$9,708
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INST
|
|
Integrative Oncogenomics of Multiple Myeloma
|
5P01CA155258-07
|
$2,065,928
|
$227,252
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INST
|
|
Patient-centered home-based hematopoietic stem cell transplantation
|
5R01CA203950-03
|
$631,375
|
$631,375
|
CHAO, NELSON
|
DUKE UNIVERSITY
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-05
|
$127,865
|
$38,360
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S1
|
$59,375
|
$1,781
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S2
|
$249,377
|
$7,481
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S3
|
$84,682
|
$2,540
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S4
|
$119,106
|
$3,573
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA014236-44
|
$5,679,062
|
$170,372
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Ionizing radiation promotes clonal expansion of premalignant cells in the thymus
|
4R00CA212198-03
|
$248,999
|
$248,999
|
LEE, CHANG LUNG
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
5R01CA136934-10
|
$357,750
|
$357,750
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$1,458
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$4,009
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$4,680
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$51,480
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-05
|
$323,700
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
$1,037,400
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-18
|
$672,442
|
$336,221
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-40
|
$250,143
|
$100,057
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Investigating the role of interleukin-22 in thymus function
|
5R00CA176376-04
|
$245,184
|
$122,592
|
DUDAKOV, JARROD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S1
|
$78,024
|
$6,242
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Organ Transplantation Research for this search: $51,345,908
|